Hiroyoshi Nishi
Mitsubishi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroyoshi Nishi.
Stroke | 1989
Hiroyoshi Nishi; Toshiaki Watanabe; Hiroko Sakurai; Satoshi Yuki; Akira Ishibashi
We induced brain edema in 72 rats by injecting 5 microliters of 3.0% wt:vol polyvinyl acetate into the left internal carotid artery, producing permanent embolization in the left cerebral hemisphere, which developed ipsilateral brain edema reproducibly. Edema was assessed 24 hours after embolization by determining the brain water content and the sodium and potassium concentrations. In this model, the free radical scavenger MCI-186 at 1.0 and 3.0 mg/kg i.v. prevented brain edema in a dose-dependent manner. At 3.0 mg/kg i.v., MCI-186 significantly reduced water content by 1.5% and improved the sodium-potassium balance to within the normal range in the embolized left hemisphere. Dexamethasone at 1.0 mg/kg i.v. did but at 3.0 mg/kg i.v. did not significantly inhibit the development of brain edema. Indomethacin at 4.0 mg/kg i.p. had no effect on brain edema. We suggest that the cyclooxygenase metabolites of arachidonic acid liberated from neuronal cell membrane phospholipids are not likely to be involved in the pathogenesis of permanent brain edema induced by polyvinyl acetate. Our results suggest that MCI-186 attenuates brain edema by suppressing the production of lipoxygenase metabolites, including free radicals or lipid peroxides, and that it may prove valuable for the treatment of brain edema associated with cerebral ischemia.
Redox Report | 2003
Kazutoshi Watanabe; Yasuhiro Morinaka; Katsuhiko Iseki; Toshiaki Watanabe; Satoshi Yuki; Hiroyoshi Nishi
Abstract This paper describes the discovery of a novel free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone, 1), as a potent antioxidant agent against lipid peroxidation. The structure-activity relationship of edaravone indicated that lipophilic substituents were essential to show its lipid peroxidation-inhibitory activity. In vivo studies revealed that edaravone showed brain-protective activity in a transient ischemia model.
Bioorganic & Medicinal Chemistry Letters | 2008
Kazutoshi Watanabe; Yasuhiro Morinaka; Yoshio Hayashi; Masaki Shinoda; Hiroyoshi Nishi; Nobuko Fukushima; Toshiaki Watanabe; Akira Ishibashi; Satoshi Yuki; Masahiko Tanaka
A series of 5-phenyl-substituted-N-alkyl-imidazolin-2-ones with potent radical-scavenging activity and lipid peroxidation inhibitory activity was synthesized. Many of the compounds showed memory-improving effect in animal models independent of the inhibitory activity on lipid peroxidation.
Archive | 1986
Hiroyoshi Nishi; Toshiaki Watanabe; Satoshi Yuki; Yasuhiro Morinaka; Katsuhiko Iseki; Hiroko Sakurai
Archive | 1987
Hiroyoshi Nishi; Toshiaki Watanabe; Satoshi Yuki; Yasuhiro Morinaka; Katsuhiko Iseki; Hiroko Sakurai
Archive | 1990
Yasuhiro Morinaka; Hiroyoshi Nishi; Toshiaki Watanabe; Satoshi Yuki; Hiroko Sakurai; Yoshio Hayashi; Nobuko Fukushima
Archive | 1990
Yoshio Hayashi; Yasuhiro Morinaka; Masaki Shinoda; Hiroyoshi Nishi; Kazutoshi Watanabe; Nobuko Fukushima
Folia Pharmacologica Japonica | 1987
Satoshi Yuki; Mitsuo Hanazuka; Toshiaki Watanabe; Hiroyoshi Nishi
Journal of pharmacobio-dynamics | 1981
Hiroyoshi Nishi; Shigenori Watanabe; Showa Ueki
Archive | 1990
Yoshio Hayashi; Yasuhiro Morinaka; Masaki Shinoda; Hiroyoshi Nishi; Kazutoshi Watanabe; Nobuko Fukushima